199 related articles for article (PubMed ID: 12101266)
1. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Griffith TS; Link BK; Weiner GJ
J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
[TBL] [Abstract][Full Text] [Related]
3. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
[TBL] [Abstract][Full Text] [Related]
4. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
Lei XY; Zhang H; He DM
Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
[TBL] [Abstract][Full Text] [Related]
5. Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference.
Castro JE; Prada CE; Aguillon RA; Kitada S; Fukuda T; Motta M; Wu C; Dicker F; Sun G; Wang JY; Carson DA; Reed JC; Kipps TJ
Leukemia; 2006 Apr; 20(4):680-8. PubMed ID: 16498393
[TBL] [Abstract][Full Text] [Related]
6. G3139 induces cell death by caspase-dependent and -independent apoptosis on human melanoma cell lines.
Nakamura S; Inui M; Kamei T; Nakase M; Okumura K; Tagawa T
Oncol Rep; 2006 Jun; 15(6):1563-8. PubMed ID: 16685396
[TBL] [Abstract][Full Text] [Related]
7. [Apoptosis increased by bcl-2 antisense ODN in MCF-7 cell line].
Zheng J; Yao Z
Zhonghua Wai Ke Za Zhi; 1999 Jul; 37(7):418-20. PubMed ID: 11829877
[TBL] [Abstract][Full Text] [Related]
8. CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens.
Jahrsdörfer B; Hartmann G; Racila E; Jackson W; Mühlenhoff L; Meinhardt G; Endres S; Link BK; Krieg AM; Weiner GJ
J Leukoc Biol; 2001 Jan; 69(1):81-8. PubMed ID: 11200072
[TBL] [Abstract][Full Text] [Related]
9. CpG-oligodeoxynucleotide protects immune cells from gamma-irradiation-induced cell death.
Sohn WJ; Lee KW; Choi SY; Chung E; Lee Y; Kim TY; Lee SK; Choe YK; Lee JH; Kim DS; Kwon HJ
Mol Immunol; 2006 Mar; 43(8):1163-71. PubMed ID: 16122803
[TBL] [Abstract][Full Text] [Related]
10. Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.
Lopes de Menezes DE; Hudon N; McIntosh N; Mayer LD
Clin Cancer Res; 2000 Jul; 6(7):2891-902. PubMed ID: 10914739
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.
Sanz L; Garcia-Marco JA; Casanova B; de La Fuente MT; García-Gila M; Garcia-Pardo A; Silva A
Biochem Biophys Res Commun; 2004 Mar; 315(3):562-7. PubMed ID: 14975737
[TBL] [Abstract][Full Text] [Related]
12. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
Yi AK; Chang M; Peckham DW; Krieg AM; Ashman RF
J Immunol; 1998 Jun; 160(12):5898-906. PubMed ID: 9637502
[TBL] [Abstract][Full Text] [Related]
13. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
[TBL] [Abstract][Full Text] [Related]
14. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression.
Mapara MY; Bargou R; Zugck C; Döhner H; Ustaoglu F; Jonker RR; Krammer PH; Dörken B
Eur J Immunol; 1993 Mar; 23(3):702-8. PubMed ID: 7680614
[TBL] [Abstract][Full Text] [Related]
15. [Bcl-2 antisense oligodeoxyribonucleotide increases apoptosis of lung carcinoma cells induced by cisplatin].
Ouyang N; Ran P; Qiu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Dec; 23(12):722-4. PubMed ID: 11778475
[TBL] [Abstract][Full Text] [Related]
16. [The inhibitory effect of bcl-2 antisense oligodeoxynucleotide/RNA on the growth of cervical carcinoma in vitro].
Mi R; Wang H; Qu Q
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):105-8. PubMed ID: 11809111
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
Loomis R; Carbone R; Reiss M; Lacy J
Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
[TBL] [Abstract][Full Text] [Related]
18. [Effect of phosphorothioate antisense Bcl-xL oligodeoxynucleotides on apoptosis and thermosensitivity of BcaCD885 cells].
He YW; Bian L; Liang XH
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):112-4. PubMed ID: 15190790
[TBL] [Abstract][Full Text] [Related]
19. [Apoptosis of human gastric cancer cells induced by bcl-2 antisense oligodeoxynucleotides].
Lu P; Chen J
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):253-5. PubMed ID: 11776807
[TBL] [Abstract][Full Text] [Related]
20. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
